Male Lower Urinary Tract Symptoms – Epidemiology – Epidemiology Dashboard
Clarivate Epidemiology's coverage of male LUTS comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of male LUTS for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe and Japan, and 10 years for the other countries covered in this report.
Clarivate Epidemiology's male LUTS forecast will answer the following questions:
- Of all men with LUTS, how many in each country across the developed world have been formally diagnosed?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of male LUTS over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts nine male LUTS patient populations, as follows:
- Total prevalent cases.
- Mild prevalent cases.
- Moderate prevalent cases.
- Severe prevalent cases.
- Total prevalent cases with comorbid erectile dysfunction (ED).
- Mild prevalent cases with comorbid ED.
- Moderate prevalent cases with comorbid ED.
- Severe prevalent cases with comorbid ED.
- Diagnosed prevalent cases.
Note: Coverage may vary by country.
Table of contents
- Male Lower Urinary Tract Symptoms - Epidemiology - Epidemiology Dashboard
- Introduction
- Male Lower Urinary Tract Symptoms Epidemiology Dashboard
- Introduction
Navya Vardhan, M.Sc., Epidemiologist, Epidemiology. She obtained her M.Sc. in biostatistics and demography from the International Institute for Population Sciences in Mumbai. She also holds a B.Sc. in mathematics.
Stephanie Niquita Phankon, M.B.B.S., M.P.H., Manager, Epidemiology. Ms. Phankon’s expertise is in autoimmune and inflammatory diseases and hematological malignancies. She holds a master’s in public health specializing in epidemiology from TISS in Mumbai and a medical degree from Hubei University of Chinese Medicine in the People’s Republic of China. She has been trained as a community physician and has supervised and coordinated various governmental and nongovernmental public health projects.